See more : Beijing Yanjing Brewery Co.,Ltd. (000729.SZ) Income Statement Analysis – Financial Results
Complete financial analysis of L’Oréal S.A. (LRLCY) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of L’Oréal S.A., a leading company in the Household & Personal Products industry within the Consumer Defensive sector.
You may be interested
- Optima Technology Group Limited (OPA.AX) Income Statement Analysis – Financial Results
- Sociedad de Inversiones Oro Blanco S.A. (ORO-BLANCO.SN) Income Statement Analysis – Financial Results
- BYD Electronic (International) Company Limited (0285.HK) Income Statement Analysis – Financial Results
- AdUX SA (ADUX.PA) Income Statement Analysis – Financial Results
- Nusasiri Public Company Limited (NUSA.BK) Income Statement Analysis – Financial Results
L'Oréal S.A. (LRLCY)
About L'Oréal S.A.
L'Oréal S.A., through its subsidiaries, manufactures and sells cosmetic products for women and men worldwide. The company operates through four divisions: Consumer Products, L'oréal Luxe, Professional Products, and Active Cosmetics. It offers shampoos, hair care products, shower gels, skin care products, cleansers, hair colors, styling products, deodorants, sun care products, make-up, perfumes, etc. The company provides its products under the L'Oréal Paris, Garnier, Maybelline New York, NYX Professional Makeup, Essie, Niely, Dark and Lovely, Lancôme, Yves Saint Laurent Beauté, Giorgio Armani Beauty, Kiehl's, Urban Decay, Biotherm, Ralph Lauren, IT Cosmetics, L'Oréal Professionnel, Kérastase, Redken, Matrix, Biolage, Pureology, Decléor, Carita, Vichy, La Roche-Posay, SkinCeuticals, Roger&Gallet, CeraVe, Stylenanda, Mixa, Magic Mask, Prada, Helena Rubinstein, Valentino, Mugler, Shu Uemura, Viktor&Rolf, Azzaro, Diesel, Atelier Cologne, Cacharel, and Yue Sai brands. It sells its products through distribution channels, such as hair salons, mass-market retail channels, perfumeries, department stores, pharmacies, drugstores, medispas, branded retail, travel retail, and e-commerce. L'Oréal S.A. was founded in 1909 and is headquartered in Clichy, France.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 41.18B | 38.26B | 32.29B | 27.99B | 29.87B | 26.94B | 31.22B | 26.22B | 26.38B | 27.27B | 30.47B | 28.53B | 20.34B | 19.50B | 17.47B | 17.54B | 17.06B | 15.79B | 14.53B | 13.64B | 14.03B | 14.29B | 13.74B | 12.67B | 10.75B | 9.59B |
| Cost of Revenue | 10.77B | 10.58B | 8.43B | 7.53B | 8.06B | 7.33B | 8.83B | 7.44B | 7.60B | 7.87B | 8.79B | 8.42B | 5.85B | 5.70B | 5.16B | 5.19B | 4.94B | 4.57B | 4.35B | 4.10B | 2.52B | 2.52B | 11.64B | 10.72B | 9.19B | 8.24B |
| Gross Profit | 30.42B | 27.68B | 23.85B | 20.46B | 21.81B | 19.61B | 22.39B | 18.79B | 18.78B | 19.40B | 21.68B | 20.11B | 14.49B | 13.80B | 12.31B | 12.35B | 12.12B | 11.22B | 10.19B | 9.54B | 11.51B | 11.77B | 2.10B | 1.95B | 1.56B | 1.34B |
| Gross Profit Ratio | 73.86% | 72.35% | 73.88% | 73.09% | 73.00% | 72.78% | 71.72% | 71.63% | 71.21% | 71.15% | 71.17% | 70.48% | 71.24% | 70.78% | 70.46% | 70.43% | 71.04% | 71.06% | 70.09% | 69.94% | 82.04% | 82.37% | 15.27% | 15.39% | 14.56% | 14.01% |
| Research & Development | 1.29B | 1.14B | 1.03B | 964.40M | 985.30M | 914.40M | 1.05B | 885.38M | 855.17M | 920.66M | 1.03B | 897.09M | 720.50M | 664.70M | 609.20M | 587.50M | 559.90M | 532.50M | 496.20M | 466.60M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 7.63B | 7.03B | 6.07B | 5.64B | 6.07B | 5.62B | 6.55B | 5.53B | 5.51B | 5.87B | 6.41B | 5.91B | 4.19B | 4.05B | 3.74B | 3.77B | 3.62B | 3.31B | 3.01B | 2.84B | 2.70B | 2.76B | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 13.36B | 19.09B | 16.67B | 14.29B | 9.21B | 8.14B | 9.18B | 7.65B | 7.75B | 7.94B | 9.12B | 8.61B | 6.29B | 6.03B | 5.39B | 5.27B | 5.13B | 4.78B | 4.37B | 4.18B | 6.36B | 6.52B | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 20.98B | 19.09B | 16.67B | 14.29B | 15.28B | 13.77B | 15.73B | 13.18B | 13.26B | 13.81B | 15.53B | 14.52B | 10.48B | 10.08B | 9.12B | 9.04B | 8.74B | 8.09B | 7.38B | 7.02B | 9.07B | 9.28B | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Expenses | 0.00 | -22.50M | -20.00M | -119.50M | -125.60M | 5.00M | -4.90M | -11.00M | -105.00M | 331.10M | 327.50M | 0.00 | 0.00 | 274.80M | 247.10M | 88.40M | 871.90M | 156.60M | 9.30M | -126.20M | 0.00 | -79.90M | -124.30M | -218.80M | 0.00 | -88.60M |
| Operating Expenses | 22.27B | 20.23B | 17.69B | 15.32B | 16.26B | 14.68B | -17.15B | -14.64B | -14.33B | -15.13B | -16.75B | -15.59B | 11.20B | 10.74B | 10.01B | 9.63B | 9.30B | 8.62B | 7.87B | 7.49B | 9.55B | 9.93B | 472.50M | 409.50M | 299.00M | 276.10M |
| Cost & Expenses | 33.04B | 30.80B | 26.13B | 22.85B | 24.33B | 22.02B | -8.32B | -7.20B | -6.73B | -7.26B | -7.96B | -7.17B | 17.05B | 16.44B | 15.17B | 14.82B | 14.25B | 13.19B | 12.22B | 11.59B | 12.07B | 12.45B | 12.11B | 11.13B | 9.48B | 8.52B |
| Interest Income | 113.30M | 69.80M | 18.50M | 19.80M | 28.70M | 47.90M | 423.52M | 376.91M | 408.36M | 413.85M | 469.32M | 423.36M | 28.50M | 17.20M | 16.00M | 34.60M | -7.60M | -3.60M | -3.30M | -3.90M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 226.70M | 76.90M | 48.10M | 92.50M | 87.70M | 42.70M | 51.80M | 47.70M | 52.40M | 60.50M | 61.40M | 27.30M | 48.10M | 43.80M | 92.00M | 208.80M | 174.50M | 115.90M | 63.80M | 43.10M | 93.90M | 142.20M | 0.00 | 159.30M | 0.00 | 101.50M |
| Depreciation & Amortization | 1.72B | 1.47B | 1.46B | 1.62B | 1.60B | 1.10B | 1.15B | 985.30M | 1.00B | 935.67M | 1.02B | 910.80M | 614.30M | 734.20M | 834.00M | 706.10M | 598.50M | 579.40M | 426.90M | 413.20M | 615.20M | 721.20M | 472.50M | 409.50M | 299.00M | 276.10M |
| EBITDA | 9.94B | 9.22B | 7.88B | 6.90B | 7.46B | 6.34B | 5.82B | 5.47B | 5.44B | 4.81B | 4.76B | 4.40B | 4.13B | 3.93B | 3.40B | 3.55B | 4.29B | 3.27B | 2.87B | 2.52B | 2.58B | 2.56B | 2.10B | 1.95B | 1.56B | 1.34B |
| EBITDA Ratio | 24.15% | 24.68% | 25.67% | 26.41% | 26.00% | 23.89% | 22.38% | 21.96% | 21.50% | 20.57% | 20.17% | 19.64% | 20.77% | 20.94% | 19.44% | 20.22% | 25.14% | 20.72% | 19.75% | 18.45% | 18.38% | 17.93% | 15.27% | 15.39% | 14.56% | 14.01% |
| Operating Income | 8.14B | 7.46B | 6.16B | 5.21B | 5.55B | 4.92B | 5.61B | 4.72B | 4.67B | 4.67B | 5.13B | 4.69B | 3.29B | 3.06B | 2.30B | 2.72B | 2.83B | 2.54B | 2.28B | 1.96B | 1.66B | 1.78B | 1.63B | 1.54B | 1.27B | 1.07B |
| Operating Income Ratio | 19.77% | 19.49% | 19.08% | 18.61% | 18.57% | 18.27% | 17.97% | 18.00% | 17.71% | 17.14% | 16.82% | 16.44% | 16.19% | 15.68% | 13.16% | 15.53% | 16.57% | 16.09% | 15.66% | 14.39% | 11.84% | 12.45% | 11.83% | 12.16% | 11.78% | 11.13% |
| Total Other Income/Expenses | -142.30M | 155.10M | -113.40M | -432.50M | -136.10M | 261.80M | 326.90M | -209.00M | 144.30M | -13.80M | 164.60M | 193.90M | 174.10M | 95.00M | 171.10M | -93.00M | 690.00M | 35.90M | 103.80M | 97.70M | 208.90M | -79.90M | -124.30M | -218.80M | -140.60M | -88.60M |
| Income Before Tax | 8.00B | 7.61B | 6.05B | 4.78B | 5.41B | 5.18B | 5.67B | 4.52B | 4.87B | 4.69B | 5.41B | 4.94B | 3.47B | 3.15B | 2.47B | 2.63B | 3.52B | 2.58B | 2.38B | 2.06B | 1.87B | 1.70B | 1.50B | 1.32B | 1.13B | 978.90M |
| Income Before Tax Ratio | 19.43% | 19.89% | 18.73% | 17.06% | 18.11% | 19.24% | 18.16% | 17.25% | 18.45% | 17.21% | 17.74% | 17.32% | 17.04% | 16.17% | 14.14% | 15.00% | 20.61% | 16.32% | 16.37% | 15.10% | 13.33% | 11.89% | 10.93% | 10.43% | 10.47% | 10.21% |
| Income Tax Expense | 1.81B | 1.90B | 1.45B | 1.21B | 1.66B | 1.28B | 1.08B | 1.28B | 1.34B | 1.34B | 1.44B | 1.30B | 1.03B | 909.90M | 676.10M | 680.70M | 859.70M | 514.70M | 405.90M | 618.60M | 628.70M | 579.80M | 535.90M | 488.50M | 428.70M | 375.00M |
| Net Income | 6.18B | 5.71B | 4.60B | 3.56B | 3.75B | 3.90B | 3.58B | 3.11B | 3.30B | 3.35B | 3.96B | 2.87B | 2.44B | 2.24B | 1.79B | 1.95B | 2.66B | 2.06B | 1.97B | 1.44B | 1.49B | 1.28B | 1.29B | 969.40M | 787.20M | 680.00M |
| Net Income Ratio | 15.02% | 14.92% | 14.24% | 12.73% | 12.55% | 14.46% | 11.47% | 11.84% | 12.50% | 12.28% | 13.01% | 10.05% | 11.99% | 11.49% | 10.26% | 11.11% | 15.57% | 13.05% | 13.57% | 10.55% | 10.63% | 8.94% | 9.39% | 7.65% | 7.32% | 7.09% |
| EPS | 11.52 | 10.65 | 8.24 | 6.37 | 6.70 | 1.39 | 8.13 | 5.75 | 6.24 | 1.15 | 1.30 | 6.01 | 0.82 | 0.76 | 0.61 | 0.66 | 0.88 | 0.67 | 0.63 | 0.44 | 0.49 | 0.43 | 0.36 | 0.29 | 0.24 | 0.21 |
| EPS Diluted | 11.52 | 10.61 | 8.21 | 6.34 | 6.66 | 1.38 | 8.14 | 5.74 | 6.25 | 1.14 | 1.30 | 6.01 | 0.82 | 0.76 | 0.61 | 0.66 | 0.88 | 0.67 | 0.63 | 0.44 | 0.49 | 0.43 | 0.36 | 0.29 | 0.24 | 0.21 |
| Weighted Avg Shares Out | 536.81M | 2.68B | 2.79B | 2.80B | 2.80B | 2.80B | 2.82B | 2.82B | 2.82B | 2.93B | 3.04B | 3.03B | 2.96B | 2.93B | 2.92B | 2.94B | 3.00B | 3.07B | 3.15B | 3.15B | 3.38B | 3.38B | 3.38B | 3.38B | 3.38B | 3.38B |
| Weighted Avg Shares Out (Dil) | 537.02M | 2.69B | 2.80B | 2.81B | 2.81B | 2.82B | 2.82B | 2.82B | 2.83B | 2.93B | 3.04B | 3.03B | 2.99B | 2.96B | 2.92B | 2.95B | 3.03B | 3.08B | 3.15B | 3.25B | 3.38B | 3.38B | 3.38B | 3.38B | 3.38B | 3.38B |
L'Oreal: An Incredibly High Quality Expensive Business
L'Oreal is the premier beauty business, with over 30 brands contributing to a market-leading position. L'Oreal's growth has been consistent and robust in the last decade, with industry tailwinds expected to support this level going forward. Margins are equally attractive,...
3 Stocks to Buy for a Billionaire-Backed Portfolio
It pays to invest in stocks with billionaire-backing. How's that, you ask?
L'Oreal SA (LRLCY) Upgraded to Buy: What Does It Mean for the Stock?
L'Oreal SA (LRLCY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
L'Oréal's Latest Acquisition Could Be a Game Changer
L'Oreal recently acquired the Aēsop cosmetics brand for $2.5 billion. Several luxury brand companies and private equity firms were competing for it.
Buy These "Beauty" Stocks for More Gains?
Hopes of a less hawkish FED could boost the Consumers Staples sector with several stocks among the Zacks Cosmetic Industry standing out in particular.
Is There More Room For Growth In L'Oreal Stock?
L'Oreal stock has risen from $72 in early January to $92 now.
Natura & Co stock falls on investor concerns regarding Aesop sale to L'Oreal
Natura & Co, the Brazilian personal care giant, saw its shares decline following news of the sale of its luxury skincare brand Aesop to L'Oreal for US$2.5 billion. Shares of Natura & Co were down 8% at US$4.83 at the...
L'Oreal Sets Eyes on Chinese Consumers, Buys Luxury Brand Aesop
L'Oreal's acquisition of the Australian luxury brand Aesop from Natura & Co., announced Monday (April 3), for an enterprise value of $2.53 billion, sets L'Oreal to expand its presence in the high-end skincare market and facilitate international expansion, especially in...
L'Oreal buys Aesop in $2.5 billion deal, its biggest acquisition ever
L'Oreal is buying Australian brand Aesop in a deal that values it at $2.5 billion, in the biggest brand acquisition ever made by the French beauty giant.
L'Oreal agrees to buy Aesop in $2.5 billion deal
L'Oreal OR, +1.02% on Monday said it had signed an agreement with Natura & Co to acquire Australian premium beauty-products maker Aesop in a $2.525 billion deal. L'Oreal executives said the move to buy Aesop — which makes plant-based hair...
Source: https://incomestatements.info
Category: Stock Reports